# SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance
Canonical URL: https://biopharmsignal.com/news/SIBN/si-bone-inc-reports-financial-results-for-the-third-quarter-2025-and-raises-2025-guidance
Ticker: SIBN
Company: Si-Bone
Source: Si-Bone
Published: 2025-11-10 21:09 EST
Original Source URL: https://investor.si-bone.com
## Summary

Delivered ~ 21% worldwide revenue growth, ~ 5% adjusted EBITDA margin, and positive cash from operating activities in the quarter Third Quarter 2025 Financial Highlights (all   comparisons are to the prior year period) Worldwide revenue of $48.7 million , representing growth of 20.6%   U.S.

## Article Body
Delivered ~ 21% worldwide revenue growth, ~ 5% adjusted EBITDA margin, and positive cash from operating activities in the quarter Third Quarter 2025 Financial Highlights (all   comparisons are to the prior year period) Worldwide revenue of $48.7 million , representing growth of 20.6%   U.S.
## Recent Company News
- 2026-05-11 20:09 EST — [SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance](https://biopharmsignal.com/news/SIBN/si-bone-inc-reports-financial-results-for-the-first-quarter-2026-and-raises-2026-guidance) — Source: Si-Bone
- 2026-04-30 20:09 EST — [SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026](https://biopharmsignal.com/news/SIBN/si-bone-to-present-at-bofa-securities-2026-healthcare-conference-on-may-12-2026) — Source: Si-Bone
- 2026-04-20 20:09 EST — [SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026](https://biopharmsignal.com/news/SIBN/si-bone-to-report-first-quarter-2026-financial-results-on-may-11-2026) — Source: Si-Bone
- 2026-02-23 21:09 EST — [SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance](https://biopharmsignal.com/news/SIBN/si-bone-inc-reports-record-financial-results-for-the-fourth-quarter-2025-and-issues-2026-guidance) — Source: Si-Bone
- 2026-02-17 21:30 EST — [SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026](https://biopharmsignal.com/news/SIBN/si-bone-to-present-at-td-cowen-46th-annual-health-care-conference-on-march-2-2026) — Source: Si-Bone
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)